KR101706019B1 - The tofu manufacturing method of containing the functional active ingredient - Google Patents
The tofu manufacturing method of containing the functional active ingredient Download PDFInfo
- Publication number
- KR101706019B1 KR101706019B1 KR1020160109112A KR20160109112A KR101706019B1 KR 101706019 B1 KR101706019 B1 KR 101706019B1 KR 1020160109112 A KR1020160109112 A KR 1020160109112A KR 20160109112 A KR20160109112 A KR 20160109112A KR 101706019 B1 KR101706019 B1 KR 101706019B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- tofu
- parts
- mixture
- active ingredient
- Prior art date
Links
- 235000013527 bean curd Nutrition 0.000 title claims abstract description 47
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 14
- 239000004480 active ingredient Substances 0.000 title abstract description 29
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 20
- 244000068988 Glycine max Species 0.000 claims description 19
- 235000010469 Glycine max Nutrition 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 13
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims description 13
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 12
- 238000000855 fermentation Methods 0.000 claims description 9
- 230000004151 fermentation Effects 0.000 claims description 9
- 235000013336 milk Nutrition 0.000 claims description 9
- 239000008267 milk Substances 0.000 claims description 9
- 210000004080 milk Anatomy 0.000 claims description 9
- 239000000701 coagulant Substances 0.000 claims description 8
- 239000004575 stone Substances 0.000 claims description 8
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 7
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 235000010493 xanthan gum Nutrition 0.000 claims description 6
- 239000000230 xanthan gum Substances 0.000 claims description 6
- 229920001285 xanthan gum Polymers 0.000 claims description 6
- 229940082509 xanthan gum Drugs 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 229920002907 Guar gum Polymers 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 4
- 239000000665 guar gum Substances 0.000 claims description 4
- 235000010417 guar gum Nutrition 0.000 claims description 4
- 229960002154 guar gum Drugs 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000032683 aging Effects 0.000 claims description 2
- 239000011874 heated mixture Substances 0.000 claims description 2
- 238000000465 moulding Methods 0.000 claims description 2
- 238000009499 grossing Methods 0.000 claims 1
- 244000163122 Curcuma domestica Species 0.000 abstract description 11
- 235000003373 curcuma longa Nutrition 0.000 abstract description 11
- 239000000796 flavoring agent Substances 0.000 abstract description 4
- 235000019634 flavors Nutrition 0.000 abstract description 4
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 235000019640 taste Nutrition 0.000 description 15
- 235000003392 Curcuma domestica Nutrition 0.000 description 10
- 235000013976 turmeric Nutrition 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 210000003128 head Anatomy 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 241000269821 Scombridae Species 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 235000020640 mackerel Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 208000024827 Alzheimer disease Diseases 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 229940099112 cornstarch Drugs 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 235000019629 palatability Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- 244000247812 Amorphophallus rivieri Species 0.000 description 2
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 235000011511 Diospyros Nutrition 0.000 description 2
- 244000236655 Diospyros kaki Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920002752 Konjac Polymers 0.000 description 2
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 2
- 244000057214 Stachys sieboldii Species 0.000 description 2
- 235000005116 Stachys sieboldii Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- -1 alcohol glycosides Chemical class 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 230000002612 cardiopulmonary effect Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000003920 cognitive function Effects 0.000 description 2
- 235000012754 curcumin Nutrition 0.000 description 2
- 229940109262 curcumin Drugs 0.000 description 2
- 239000004148 curcumin Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000001506 immunosuppresive effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000252 konjac Substances 0.000 description 2
- 235000010485 konjac Nutrition 0.000 description 2
- 229930013686 lignan Natural products 0.000 description 2
- 150000005692 lignans Chemical class 0.000 description 2
- 235000009408 lignans Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 229920006389 polyphenyl polymer Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 235000013322 soy milk Nutrition 0.000 description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241001094255 Elytraria Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241001547125 Fritillaria thunbergii Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 241001233945 Kazachstania Species 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000010909 Monoamine Oxidase Human genes 0.000 description 1
- 108010062431 Monoamine oxidase Proteins 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 241001400472 Omiza Species 0.000 description 1
- 241000179039 Paenibacillus Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000656145 Thyrsites atun Species 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229930185474 acteoside Natural products 0.000 description 1
- FBSKJMQYURKNSU-ZLSOWSIRSA-N acteoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)\C=C\C=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O FBSKJMQYURKNSU-ZLSOWSIRSA-N 0.000 description 1
- FBSKJMQYURKNSU-UKQWSTALSA-N acteoside I Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO)[C@H]2OC(=O)C=Cc4ccc(O)c(O)c4)[C@H](O)[C@H](O)[C@H]1O FBSKJMQYURKNSU-UKQWSTALSA-N 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 208000015669 capillary disease Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000006993 memory improvement Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 239000002581 neurotoxin Substances 0.000 description 1
- 231100000618 neurotoxin Toxicity 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229930184487 stachysoside Natural products 0.000 description 1
- 208000026843 stiff neck Diseases 0.000 description 1
- 208000023516 stroke disease Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Abstract
Description
본 발명은 기능성 유효성분이 함유된 두부 및 그 제조방법에 관한 것으로, 더 상세하게는 강황, 오미자 등이 함유되어 다양한 유효성분을 손쉽게 섭취할 수 있음은 물론, 맛과 기호도에서도 기존의 기능성 두부에 비해 향상된 기능성 유효성분이 함유된 두부 및 그 제조방법에 관한 것이다.The present invention relates to a tofu containing a functional active ingredient and a preparation method thereof. More particularly, the present invention relates to a tofu containing a functional active ingredient, The present invention relates to a tofu containing an improved functional ingredient and a process for producing the same.
일반적으로, 두부는 불린 콩을 갈고 비지를 걸러낸 후 콩물을 가열하고 여기에 응고제를 첨가하여 굳힌 식물성 고단백 식품으로서, 이러한 두부는 제조방법에 따라 여러 가지 종류가 있는데, 예컨대, 콩물을 끓여 응고제를 넣고 수분 함량 85% 정도로 압착 탈수한 일반두부, 콩물을 끓여 응고제를 넣고 멍울이 진 것을 눌러 굳히지 않은 순두부, 일반두부와 순두부의 중간정도의 굳기로 용기에 콩물과 응고제를 넣고 그대로 가열해서 만든 연두부 등이 있다.Generally, tofu is a vegetable high-protein food which is made by baking soybeans and filtering out the beans, heating the beans and adding a coagulant thereto. There are various kinds of tofu according to the manufacturing method. For example, Tofu, which is made by squeezing the dehydrated water to 85% of moisture content, boiled soybeans, putting the coagulant in it and pressing the lid to make it hard, medium hardness between the tofu and tofu, .
상기 두부는 맛이 부드럽고 담백하며 소화율이 좋은데다가 성장과 발육, 신진대사에 필요한 단백질이 풍부하고 칼슘 및 식물성 지방이 많이 들어있어 영양이 우수하면서도 칼로리가 낮은 편이어서 다이어트 식품으로도 많이 이용되고 있다.The tofu is rich in proteins necessary for growth and development, metabolism, and contains a lot of calcium and vegetable fat, so that it has a good taste and softness and a good digestibility and is also used as a diet food because it has excellent nutrition and low calorie.
그러나 두부에는 기타 영양성분은 함유되지 있지 않으므로 여러 가지 유효성분들을 효율적으로 보충하기 위해서는 다른 식품을 함께 섭취할 필요가 있고, 또한 담백하기는 하나 다소 싱겁고 밋밋한 맛을 가진데다가 색상도 흰색으로 제한되어 있는 단점이 있다.However, tofu does not contain other nutritional ingredients. Therefore, it is necessary to take other foods together to efficiently supplement the various effective ingredients, and it is also chewy, but has a slightly sour, flat taste and color is limited to white There are disadvantages.
이를 위하여 종래에는 두부를 제조하는 과정에서 녹차가루, 버섯, 한약재, 허브 등을 포함하여 두부의 영양가를 높이고 맛을 보강하는 방법이 개시되어 있으나, 한약재의 경우 특유의 향과 쓴맛으로 인해 기호성이 떨어지는 문제가 있다.For this purpose, a method of enhancing the nutritive value and enhancing the nutritional value of tofu including green tea powder, mushroom, herbal medicine, and herb in the process of manufacturing tofu has been disclosed in the past, but in the case of herbal medicines, there is a problem.
또한, 대한민국 공개특허 제10-2014-0080906호에는 오디, 오미자, 치자, 강황 등에서 추출한 천연색소를 이용한 두부 제조방법이 개시되어 있으며, 다양한 색상을 구현할 수 있다는 기술적 특징을 가지고 있는데, 초음파 추출 과정에서 유효 성분이 파괴되거나 변질될 우려가 있다.Korean Patent Laid-Open Publication No. 10-2014-0080906 discloses a method of manufacturing a tofu using natural pigments extracted from Audi, Omija, Chiza, and Kunghuang, and has a technical feature that various colors can be realized. In the ultrasonic extraction process The active ingredient may be destroyed or altered.
또 다른 일례로, 대한민국 등록특허 제10-1613045호에는 과일의 껍질과 과육을 이용한 두부의 제조방법이 개시되어 있는데, 과육 곤약에 의해 기존 두부와 다른 식감을 제공하는 기술적 특징이 있다. 다만, 기호에 따라서는 과육 곤약에 의한 식감이 소비자의 기호도를 떨어뜨릴 수 있으며, 제조 공정의 난이도 내지 비용 증가에 비해 두부에 함유되는 영양 성분 내지 유효 성분 다양하지 않고, 특유의 효능을 제공하지 못하는 제한이 있다.In another example, Korean Patent Registration No. 10-1613045 discloses a method for producing tofu using the skin of fruit and pulp, which has technical features to provide a texture different from that of conventional tofu by means of persimmon konjac. However, depending on the preference, the texture of the persimmon konjac may deteriorate the preference of the consumer, and the nutritional composition or the active ingredient contained in the tofu does not vary compared with the difficulty or cost increase of the manufacturing process, There is a limit.
한편, 초석잠(Stachys Sieboldii)은 중국의 전통 건강채소로서, 여름에는 잎이 무성하고, 겨울에는 뿌리가 3~6cm 정도로 누에모양이며, 특히 동충하초의 모양과 약리적 효능이 유사하기 때문에 식물의 동충하초라 한다. 중국에는 대표적인 장수 채소로서 중약편에 의하면, 뇌경색, 기억력 증진, 인지기능저하개선, 노인성 치매와 장의 기능을 촉진시켜 주는 유용 소재로 이용되고 있다.On the other hand, Stachys Sieboldii is a traditional Chinese health vegetable, with leaves in summer and silkworms 3-6cm long in winter. In particular, the shape and pharmacological effects of Chinese caterpillar fungus are similar, do. China is a representative long-lived vegetable, according to the Chinese medicine, cerebral infarction, memory, improve cognitive function, improve the function of senile dementia and intestines are used as useful materials.
이러한 초석잠은 약리적 효능에도 불구하고 약재로만 인식되어 우리나라 국민들이 즐겨먹는 주요 식재료 중 하나인 두부에는 전혀 적용된 적이 없는 실정이다. 마찬가지로, 천패모와, 괴화도 한약재로만 이용되고 있을 뿐 두부에서는 전혀 사용되지 않아 그 유효성분을 일반인들이 손쉽게 섭취하기 어려운 실정이다.Despite its pharmacological efficacy, this groundbreaking sleep has never been applied to tofu, which is one of the main food ingredients enjoyed by the Korean people. Likewise, it is difficult to eat the active ingredient easily because it is used only as a herbal medicine and as a herbal medicine only in a tofu.
상기와 같은 문제점을 해결하기 위해 본 발명은 강황, 오미자 등이 함유되어 다양한 유효성분을 손쉽게 섭취할 수 있음은 물론, 맛과 기호도에서도 기존의 기능성 두부에 비해 향상된 기능성 유효성분이 함유된 두부 및 그 제조방법을 제공함에 있다.In order to solve the above-mentioned problems, the present invention is to provide a tofu containing a functional active ingredient as compared to a conventional functional tofu, in taste and taste, as well as being capable of easily ingesting various active ingredients, Method.
본 발명의 해결하고자 하는 과제는 이상에서 언급된 것들에 한정되지 않으며, 언급되지 아니한 다른 해결과제들은 아래의 기재로부터 당업자에게 명확하게 이해되어 질 수 있을 것이다.The problems to be solved by the present invention are not limited to those mentioned above, and other solutions not mentioned can be clearly understood by those skilled in the art from the following description.
이러한 본 발명의 목적을 달성하기 위한 수단으로서, 본 발명에 따른 기능성 유효성분이 함유된 두부는 강황과, 오미자의 유효성분을 포함하는 것을 특징으로 한다.As means for achieving the object of the present invention, the tofu containing the functional active ingredient according to the present invention is characterized by containing an active ingredient of turmeric and omija.
또한, 본 발명에 따른 기능성 유효성분이 함유된 두부에 있어서, 초석잠의 유효성분을 더 포함하는 것을 특징으로 한다.In addition, the tofu containing the functional active ingredient according to the present invention is further characterized by containing an effective ingredient for cornerstone sleep.
또한, 본 발명에 따른 기능성 유효성분이 함유된 두부에 있어서, 천패모와, 괴화의 유효성분을 더 포함하는 것을 특징으로 한다.Further, in the head containing the functional active ingredient according to the present invention, it is further characterized in that it further comprises an active ingredient of the bean curd and the bean curd.
또한, 본 발명에 따른 기능성 유효성분이 함유된 두부에 있어서, 각 유효성분의 총 중량은 두부 총 중량 대비 1~10중량% 함유되는 것을 특징으로 한다.In addition, in the head containing the functional active ingredient according to the present invention, the total weight of each effective ingredient is 1 to 10% by weight based on the total weight of the head.
또한, 본 발명에 따른 기능성 유효성분이 함유된 두부의 제조방법은 강황을 증숙한 다음 건조하고, 건조된 강황을 분쇄하여 강황 분말을 마련하는 S1단계와; 오미자 즙을 마련하는 S2단계와; 상기 오미자 즙 100중량부를 기준으로 증류수 50~150중량부와, 상기 강황 분말 10~30중량부와, 잔탄검 또는 구아검 1~5중량부를 혼합한 다음, 70~90℃에서 30~50분 동안 가열한 혼합물을 제조하는 S3단계와; 초석잠을 열수추출한 추출액을 마련하는 S4단계와; 천패모와, 괴화를 열수추출한 다음, 발효시키는 S5단계와; 불린 대두를 마쇄하고 가열 후 여과하여 두유를 얻는 S6단계와; 상기 두유 100중량부에 상기 S3단계에서 제조된 혼합물 0.1~1중량부와, 상기 S4단계 초석잠 추출액 1~3중량부와, 상기 S5단계의 발효액 0.1~1중량부를 혼합하고 가열하는 S7단계와; 상기 S7단계에서 가열한 혼합물에 응고제를 넣고 성형하는 S8단계;를 포함하는 것을 특징으로 한다.In addition, the method for preparing a curd containing the functional active ingredient according to the present invention comprises: S1: a step of drying a dried sulfuric acid, pulverizing the dried sulfuric acid to prepare a sulfur powder; Step S2 of preparing omija juice; 50 to 150 parts by weight of distilled water, 10 to 30 parts by weight of the sulfurized powder, and 1 to 5 parts by weight of xanthan gum or guar gum are mixed with 100 parts by weight of the above omija juice, and the mixture is stirred at 70 to 90 ° C for 30 to 50 minutes Preparing a heated mixture; (S4) of preparing an extract to be extracted as hot stone water; A step S5 of extracting hot water from the seedlings and fermenting the seeds; S6 step of grinding the so-called soybeans, heating and filtering to obtain soybean milk; Step S7 is a step of mixing and heating 0.1 to 1 part by weight of the mixture prepared in the step S3, 1 to 3 parts by weight of the sleeping extract of the step S4 and 0.1 to 1 part by weight of the fermentation solution of the step S5 in 100 parts by weight of the soybean milk ; And a step S8 of injecting a coagulant into the mixture heated in step S7 and molding the mixture.
본 발명에 따른 기능성 유효성분이 함유된 두부 및 그 제조방법은 강황, 오미자, 초석잠, 천패모, 괴화 등이 함유되어 다양한 유효성분을 손쉽게 섭취할 수 있음은 물론, 맛과 기호도에서도 우수하다.The tofu containing the functional active ingredient according to the present invention and the preparation method thereof can be easily ingested with various active ingredients since it contains ghuldang, omija, cornstarch, bean curd, bean curd, etc., and is also excellent in taste and preference.
본 발명의 효과는 이상에서 언급된 것들에 한정되지 않으며, 언급되지 아니한 다른 해결과제들은 아래의 기재로부터 당업자에게 명확하게 이해되어 질 수 있을 것이다.The effects of the present invention are not limited to those mentioned above, and other solutions not mentioned may be clearly understood by those skilled in the art from the following description.
도 1은 본 발명에 따른 기능성 유효성분이 함유된 두부 제조방법의 각 단계를 도시하는 블럭도이다.BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a block diagram showing each step of a method for producing a head containing a functional active ingredient according to the present invention. FIG.
이하, 첨부된 도면들 및 후술 되어 있는 내용을 참조하여 본 발명의 바람직한 실시예들을 상세히 설명한다. 그러나, 본 발명은 여기서 설명되는 실시예들에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 실시예들은 개시된 내용이 철저하고 완전해질 수 있도록 그리고 당업자에게 본 발명의 기술적 사상이 충분히 전달될 수 있도록 하기 위해 제공되어 지는 것이다.Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings and the following description. However, the present invention is not limited to the embodiments described herein but may be embodied in other forms. Rather, the embodiments disclosed herein are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art.
도 1은 본 발명에 따른 기능성 유효성분이 함유된 두부 제조방법의 각 단계를 도시하는 블럭도이다.BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a block diagram showing each step of a method for producing a head containing a functional active ingredient according to the present invention. FIG.
도 1을 참조하면, 본 발명에 따른 기능성 유효성분이 함유된 두부 제조방법은 복수의 기능성 유효성분을 첨가하되 두부 고유의 맛과 풍미를 유지하고 기호성을 향상시킬 수 있도록 구성되는 것으로서, S1단계 내지 S8단계를 포함할 수 있다.Referring to FIG. 1, a method for producing a curd containing a functional active ingredient according to the present invention comprises adding a plurality of functional active ingredients to maintain taste and flavor inherent to tofu and to improve palatability. Step < / RTI >
본 발명의 S1단계는 강황을 증숙한 다음 건조하고, 건조된 강황을 분쇄하여 강황 분말을 마련하는 단계이다.The step (S1) of the present invention is a step of drying the sulfuric acid after drying the sulfuric acid, and pulverizing the dried sulfuric acid to prepare a sulfuric acid powder.
상기 강황은 도금(都金) 또는 울금(鬱金))이라고도 하며, 식용으로 판매되는 강황 분말은 주로 근경을 물을 넣고 쪄서 쓴맛을 없앤 후 오븐에서 말린 후 갈아서 제조된 것으로, 짙은 노란색 또는 주황색을 띈다. 강황의 주요 기능성 유효성분은 커큐민으로서 항산화작용, 항암작용, 항당뇨작용, 항염작용, 간기능보호, 치매예방 및 체내 지방축적억제 작용 등의 생리활성을 가지는 것으로 알려져 있다.The turmeric powder is also referred to as "gold" or "gold"). The powder of turmeric sold for food is usually prepared by grinding after drying in an oven after putting water into the rhizome and steam-boiling it. The powder is dark yellow or orange . It is known that curcumin has a physiological activity such as antioxidative action, anti-cancer action, anti-diabetic action, anti-inflammatory action, protection of liver function, prevention of dementia and inhibition of accumulation of body fat in curcumin.
상기 강황의 주요 기능성 유효성분은 커큐민은 물에 잘 녹지 않는 난용성 물질이어서 수분산성을 높일 수 있도록 강황을 증숙한 다음 분쇄하고, 후술할 잔탄검 또는 구아검과 혼합하는 것이 바람직하다.The main functional active ingredient of the turmeric is preferably an insoluble substance which is insoluble in water, so that the turmeric is mixed with the xanthan gum or guar gum which will be described later after ripening the sulfuric acid so as to enhance the water dispersibility.
본 발명의 S2단계는 오미자 즙을 마련하는 단계이다.Step S2 of the present invention is a step of preparing the juice of Omija.
상기 오미자 즙은 오미자 열매를 착즙하여 얻을 수 있는데, 오미자 열매에는 비타민B1, 칼슘, 단백질, 철, 인, 사과산, 주석산 등의 유기산과, 리그난 성분이 함유되어 있다. 그리고 사과산과 주선산 등의 유기산 등은 세포의 산성화를 막아주어 노화방지 및 골관절염 완화에도 도움이 되며, 혈당을 내려주어 당뇨병 개선에 효과가 있고, 피로 회복, 혈액순환 장애를 개선하고 심장기능을 강화시키며, 리그난 성분은 파킨슨병, 뇌졸증 등의 뇌질환과 알츠하이머 등을 발병시키는 신경 독의 작용을 막아주고 뇌세포를 보호하는 효과가 있고, 동의보감에 의하면 술독해소, 간보호, 간질환 등에 효과가 있는 것으로 알려져 있다.The Schizandra chinensis juice can be obtained by juicing Schizandra chinensis. The Schizandra chinensis fruit contains organic acids such as vitamin B1, calcium, protein, iron, phosphorus, malic acid, tartaric acid, and lignan. And the organic acids such as malic acid and Zusan acid prevent the acidification of the cells, which helps prevent aging and osteoarthritis. It also helps to reduce blood sugar and improve diabetes. It also improves fatigue, improves blood circulation and strengthens heart function. The lignan component inhibits the action of neurotoxins that cause Parkinson's disease, brain diseases such as stroke and Alzheimer's disease, and protects brain cells. .
본 발명의 S3단계는 S1단계의 강황 분말과 S2단계의 오미자 즙을 혼합하여 수분산성을 높이고 강황의 독특한 맛을 오미자의 달콤하면서 신맛으로 중화시켜 기호성을 향상시키는 역할을 하는 것으로서, 상기 오미자 즙 100중량부를 기준으로 증류수 50~150중량부와, 상기 강황 분말 10~30중량부와, 잔탄검 또는 구아검 1~5중량부를 혼합한 다음, 70~90℃에서 30~50분 동안 가열한 혼합물을 제조하는 것을 예시할 수 있다.The step S3 of the present invention plays a role of enhancing the water-dispersibility by mixing the turmeric powder of the step S1 and the juice of the step of the step S2 and enhancing the palatability by neutralizing the unique taste of the turmeric with sweet and sour taste of the omelet. 50 to 150 parts by weight of distilled water, 10 to 30 parts by weight of the sulfurized powder, and 1 to 5 parts by weight of xanthan gum or guar gum are mixed and heated at 70 to 90 DEG C for 30 to 50 minutes. Can be exemplified.
여기서, 강황 분말이 10중량부 미만으로 혼합되는 경우에는 강황의 유효성분에 의한 효능을 기대하기 어렵고, 30중량부를 초과하는 경우에는 기호성이 저하되므로 상술한 범위로 제한하는 것이 바람직하다.Here, when the sulfuric acid powder is mixed at less than 10 parts by weight, it is difficult to expect the effect of the active ingredient of the sulfuric acid. When the content exceeds 30 parts by weight, the palatability is lowered.
상기 잔탄검 또는 구아검은 천연 계면활성제 역할을 한다.And serves as the xanthan gum or guar black natural surfactant.
그리고 혼합물을 70~90℃에서 30~50분 동안 가열함으로써 혼합 효율을 높일 수 있게 되는데, 70~90℃보다 높은 온도에서 가열하면 오미자 고유의 맛이 변질되고 오미자 등에 함유된 영양소가 파괴될 우려가 있기 때문에 상술한 온도범위에서 가열하는 것이 바람직하다.When the mixture is heated at 70 to 90 ° C for 30 to 50 minutes, it is possible to increase the mixing efficiency. If the mixture is heated at a temperature higher than 70 to 90 ° C, the taste of the original ozone may be altered and nutrients contained in the ozone may be destroyed It is preferable to heat at the above-mentioned temperature range.
본 발명의 S4단계는 초석잠을 열수추출한 추출액을 마련하는 단계이다.The step S4 of the present invention is a step of preparing an extract solution obtained by extracting hot water from a cornerstone.
상기 초석잠(Stachys sieboldii Miq.)은 꿀풀과의 여러해살이 식물로 초석잠의 덩이줄기 또는 전초로 이용되고 있으며, 1년생 본초로 줄기는 직립이며, 잎은 장타원형에 꽃은 8월 하순에 담홍색의 이삭형태로 개화하고 주로 중국, 일본 및 러시아 등에서 재배되었으나, 최근에는 우수한 약리적 효능과 재배의 용이성 등으로 인해 한국의 산청을 비롯한 지리산 권역에서 대규모로 재배되고 있다.The stamen sleeping (Stachys sieboldii Miq.) Is a perennial plant of Lepidoptera, and is used as a rootstock or a seedling for the foundation stone. The stem is an upright stalk. The stem is an oval shape. It is cultivated mainly in China, Japan and Russia. Recently, however, it has been cultivated on a large scale in Jilisan area including Sancheon in Korea due to its excellent pharmacological efficacy and ease of cultivation.
초석잠은 일본에서는 정월 요리에 애용되고 있으며, 다양한 성인병과 만성병 치료에 유용하게 사용되고 있으며, 중국에는 대표적인 장수채소로서 중약편에 의하면 뇌경색, 기억력 증진, 인지기능저하개선, 노인성 치매와 장의 기능을 촉진시켜 주는 유용 소재로 이용되고 있다.It is used for the treatment of various adult diseases and chronic diseases in China. It is a typical longevity vegetable in China. According to the Chinese medicine, cerebral infarction, improvement of memory, improvement of cognitive function, promotion of senile dementia and bowel function It is used as a useful material to make.
초석잠에 관한 연구는 일본과 중국에서 가장 활발하게 수행되었고, 국내에서는 초석잠 추출물의 항암 및 면역효과, 잎 추출물의 항균활성, 활성산소 소거효과, 줄기와 뿌리 추출물의 특성분석과 아질산염 소거능, 항산화 활성, acetylchoilne esterase 및 monoamine oxidase 활성 억제효과 등이 보고되었다.Studies on the foundation stone sleeping were performed most actively in Japan and China. In Korea, anticancer and immune effect, antimicrobial activity of leaf extract, active oxygen scavenging effect, characterization of stem and root extract, nitrite scavenging ability, antioxidant activity Activity, acetylchoilne esterase and monoamine oxidase activity.
외국에서는 초석잠으로부터 9개의 polyphenyl alcohol glycoside의 분리, 신규 glycoside의 분리 및 구조 결정, HPLC를 이용한 stachyose 정량, 무산소증 개선, hyalurondase 활성저해, 면역억제작용, 호르몬과 돌연변이 유도 과산화수소스펙트럼 변화 등이 보고된 바 있다. 최근에는 초석잠의 aceteoside가 면역억제를 통한 사구체 신장염을 개선시키는 데 매우 효과적임이 밝혀졌는데, 이는 사구체 내의 백혈구 수를 억제하는 데서 기인하는 것으로 나타났다.In the foreign countries, 9 polyphenyl alcohol glycosides were isolated from ground stone sleep, separation and structure determination of new glycosides, quantification of stachyose using HPLC, improvement of anaerosis, inhibition of hyaluronidase activity, immunosuppressive action and hormone and mutagenic induced hydrogen peroxide spectrum were reported There is a bar. In recent years, acetooside has been found to be very effective in improving glomerulonephritis through immunosuppression, which is attributed to inhibiting the number of white blood cells in the glomeruli.
그리고 초석잠의 기능성 유효성분은 acteoside, stachysoside, phenylethanoid glycoside와, 천연올리고당인 stachyose, saponin 등 각종 배당체, iridoidic 분획물, polyphenyl alcohol glycoside, aceteoside, choline, alginate 등이 다량 함유되어 있어 다양한 생리활성이 우수한 것으로 밝혀졌다.In addition, the functional active ingredients of cornstarch sleep are rich in various physiological activities including acteoside, stachysoside, phenylethanoid glycoside, various glycosides such as natural oligosaccharides stachyose and saponin, iridoidic fractions, polyphenyl alcohol glycoside, acetooside, choline and alginate It turned out.
이와 같이 우수한 생리활성을 가지는 초석잠은 아직까지 두부와 같은 식품에 적용된 예가 없다.There is no example of such a base stone having excellent physiological activity applied to foods such as tofu.
본 발명의 S5단계는 천패모와, 괴화를 열수추출한 다음, 효소를 넣고 발효시키는 단계이다.The step S5 of the present invention is a step of extracting hot water and raw water, followed by enzymatic fermentation.
상기 천패모(학명 : Fritillaria thunbergii Miquel)는 나리과에 속한 다년생초본인 비늘 줄기로서, 本經(본경)에서는 傷寒(상한)으로 煩熱(번열)이 나고 소변이 시원하지 않은 증상을 치료하고, 극심한 하복부 통증을 치료하고 목구멍이 부어 젖을 먹기 힘든 증상을 치료하고 金瘡傷(금창상)으로 痙攣(경련)이 일어나는 증상을 치료한다고 기재되어 있고, '別錄(별록)'에서는 뱃속에 덩어리가 맺히고 명치부위가 그득한 것을 치료하며 찬물을 끼얻은 듯한 오한을 느끼고 눈앞이 캄캄하고 뒷목이 뻣뻣해지는 것을 치료한다. 기침이 심하여 上氣(상기)되는 증상을 치료하며 가슴이 답답하고 갈증이 나고 땀이 쏟아지는 증상을 치료한다고 기재되어 있다. 또한, '陶弘景(도홍경)'에서는 貝母(패모)를 먹으면 배가 고프지 않으므로 음식을 끊을 수 있다고 기재되고, '池大明(지대명)'에서는 가래를 삭히고 心肺(심폐)를 윤택하게 한다. 가루를 내어 설탕과 섞어서 환을 만들어 입에 물고 있으면 기침이 멎는다. 약재를 태워서 기름과 혼합하여 사람과 짐승의 부스럼이 심한 곳에 바르면 상처가 아문다고 기재되어 있다.The Fritillaria thunbergii Miquel is a perennial herbaceous scaly stem belonging to the genus Lilium. It treats symptoms that are uncomfortable (uncomfortable) with urinary incontinence (upper limit) It treats lower abdominal pain, treats symptoms that it is difficult to get the throat swollen to breast milk, and treats the symptoms of spasm (spasmodic reaction) with a gold sore wound (gold wounds). In the "separate record" It treats what the area has gained, feels chills like cold water, treats darkening eyes and stiff neck. Cough is severe and it treats the symptoms that are upper (the above), and it is described that the chest is cramped, thirsty and sweating is treated. In addition, it is said that the food can be cut off because it is not hungry when the mackerel is consumed in the mackerel (mackerel). In the 'pike 大 明', the mackerel is removed and the cardiopulmonary (cardiopulmonary) is enriched. If you mix the flour with the sugar and make a circle, you will stop coughing when you are biting in your mouth. It is stated that burning of medicinal materials is mixed with oil and applied to a place where the wounds of man and animal are severe.
상기 괴화(학명 : Sophora japonica Linne)은 콩과에 속한 회화나무의 꽃봉오리로서, 혈의 열로 인한 변비, 붕루 등을 멈추게 한다. 눈이 충혈된데, 장출혈, 자궁출혈, 피를 토하는 데, 코피, 혈변을 누는데등 모세혈관장애로 인한 여러가지 출혈에 사용된다. 그리고 고혈압, 두통, 어지럼증, 동맥경화증, 중풍, 뇌일혈, 가슴이 답답한 증세에도 효과가 있다고 알려져 있다.The Sophora japonica Linne is a bud of a flower tree belonging to the bean curd, which causes constipation due to the heat of blood and blobs to stop. It is used for various bleeding due to capillary disorder such as bleeding of the eye, intestinal bleeding, bleeding of the uterus, bleeding of the blood, nosebleed, blood leaking. It is also known to have effects on hypertension, headache, dizziness, arteriosclerosis, paralysis, stroke, and chest symptoms.
이와 같이 천패모와, 괴화는 각종 효능이 알려져 있으나, 아직까지 두부와 같은 식품에 적용된 예가 없다.As described above, various effects are known for the ginseng root and the seedling, but there is no example applied to foods such as tofu.
다만, 천패모와 괴화는 초석잠과 달리 발효하는 단계를 더 거치게 되는데, 그 이유는 실험을 통해 초석잠의 경우에는 발효하지 않고 사용하더라도 두부 맛의 변화에 큰 영향이 없었으나, 천패모와 괴화는 발효시키지 않으면 맛 내지 기호도가 낮아진다는 것을 확인하였다.However, unlike the basic bedding, the bedding and the bedding are further subjected to a fermenting step because the experiment did not have a significant effect on the change of the tofu taste even when the bedding was used without the fermentation, It was confirmed that flavor and taste were lowered without fermentation.
그리고 발효에 사용되는 '발효미생물'은 통상의 효모(Saccharomyces 속), 바실러스(Bacillus속), 락토바실러스(Lactobacillus속), 페니바실러스(Paenibacillus 속), 카자흐스타니아(Kazachstania속), 또는 유용균의 조합 내지 배양 산물인 EM 균(EffectiveMicroorganisms) 중 선택되는 어느 하나 이상의 미생물인 것을 예시할 수 있으며, 30~35℃에서 10시간~2일 동안 발효시키는 것을 예시할 수 있다.The 'fermenting microorganism' used for fermentation is a combination of common yeast (Saccharomyces genus), Bacillus (genus Bacillus), Lactobacillus (genus Lactobacillus), Pennibacillus (genus Paenibacillus), Kazakhstania (genus Kazachstania) And Effective Microorganisms (EM microorganisms). Examples of the microorganisms include fermentation at 30 to 35 DEG C for 10 hours to 2 days.
본 발명의 S6단계는 불린 대두를 마쇄하고 가열 후 여과하여 두유를 얻는 과정이다. 보다 구체적으로, 선별된 대두를 세척하여 이물질을 제거하고 콩의 유효성분의 추출이 용이하도록 정수에 침지하되, 마쇄율을 높이면서도 콩에 함유된 단백질이 용출되거나 변질되지 않도록 하절기에는 4~6시간, 동절기에는 7~10시간 동안 침지하여 불린다. 이어서, 불린 대두에 정수를 첨가하면서 마쇄하여 콩물을 얻는데, 이때, 정수의 양이 너무 많으면 콩물의 농도가 낮아지면서 후공정에서 많은 양의 응고제를 필요로 하고, 너무 적을 경우에는 추출율이 저하될 뿐 아니라 콩물의 농도가 높아지면서 응고제를 균일하게 혼합하기 어려우므로 대두와 정수는 중량기준 1 : 3~6의 비율로 혼합하는 것이 좋다.The step S6 of the present invention is a process of grinding soybeans, heating them, and filtering soy milk. More specifically, the selected soybeans are washed to remove impurities and soaked in purified water so as to facilitate the extraction of the active ingredient of soybeans. However, during the summer, the protein contained in the beans is kept for 4 to 6 hours And it is dipped for 7 to 10 hours in winter. When the purified water is too much, the concentration of the bean is lowered, and a large amount of coagulant is required in the subsequent step. When the amount of the purified water is too small, the extraction rate is lowered However, it is difficult to uniformly mix the coagulant as the concentration of the bean is increased. Therefore, it is preferable to mix soybean and juice in a ratio of 1: 3 ~ 6 by weight.
그리고 대두에 포함된 미생물을 살균하고 단백질의 열 변성에 의해 흡수율이 높아지도록 상기 콩물을 가열하되, 두부의 맛과 보존성을 높이도록 고온에서 단시간 동안 가열하며, 이때 지나치게 높은 온도에서 가열시 단백질이 응고될 우려가 있으므로 온도 95~105℃에서 5~10분 동안 가열한다. 이어서, 상기 가열된 콩물을 회전원심분리기를 이용하여 두유와 비지로 분리한다.The microorganisms contained in the soybean are sterilized and the soybean is heated so as to increase the absorption rate by thermal denaturation of the protein. The soybean protein is heated at a high temperature for a short time so as to enhance the taste and preservability of the soybean curd. It is heated at 95 ~ 105 ℃ for 5 ~ 10 minutes. Then, the heated bean is separated into soybean milk and bean curd using a rotary centrifuge.
본 발명의 S7단계는 S6단계에서 분리한 두유 100중량부에 S3단계에서 제조된 혼합물 0.1~1중량부와, S4단계 초석잠 추출액 1~3중량부와, S5단계의 발효액 0.1~1중량부를 혼합하고 가열하고, S8단계에서는 S7단계에서 가열한 혼합물에 응고제를 넣고 성형하여 두부 제조를 완료하게 된다. 여기서 응고제는 수산화칼슘(Ca(OH)2) 또는 수산화나트륨(NaOH)인 것을 예시할 수 있으나, 이에 한정되는 것은 아니다.In the step S7 of the present invention, 0.1 to 1 part by weight of the mixture prepared in the step S3, 1 to 3 parts by weight of the S4 stepping stone sleeping extract and 0.1 to 1 part by weight of the fermentation solution of step S5 are added to 100 parts by weight of the soybean milk separated in the step S6 And the mixture is heated. In step S8, the coagulant is added to the mixture heated in step S7, and the mixture is molded to complete the production of the tofu. The coagulant may be, for example, calcium hydroxide (Ca (OH) 2 ) or sodium hydroxide (NaOH), but is not limited thereto.
이하에서는 본 발명에 따른 기능성 물질이 함유된 두부 제조방법의 바람직한 실시예를 설명한다.Hereinafter, a preferred embodiment of a method for producing a tofu containing a functional material according to the present invention will be described.
말린 강황을 증숙기에 넣고 3시간 동안 증숙한다. 증숙된 강황을 충분히 건조한 다음, 분쇄하여 강황 분말을 마련한다.Put the dried turmeric in a boil and cook for 3 hours. The steamed sulfuric acid is sufficiently dried, and then pulverized to prepare a sulfur powder.
오미자 열매에서 씨를 뺀 다음 착즙기로 오미자 즙을 마련한다.Remove the seed from the fruit of Omija, and then prepare juice of Omija with a juicer.
오미자 즙 1kg과, 증류수 1kg과, 강황 분말 150g과, 잔탄검 20g을 혼합한 다음, 75℃로 가열되는 용기에 넣고 40분 동안 교반하여 혼합물을 제조한다.1 kg of omija juice, 1 kg of distilled water, 150 g of a sulfurized powder, and 20 g of xanthan gum were mixed and placed in a vessel heated to 75 캜 and stirred for 40 minutes to prepare a mixture.
초석잠 1kg과 물 10리터를 약탕기에 투입하고 4시간 동안 가열하여 열수 추출한 추출액을 마련한다.1 kg of ground stone and 10 liters of water are added to a pan and heated for 4 hours to prepare an extract.
천패모 500g과, 괴화 500g과, 물 10리터를 약탕기에 투입하고 4시간 동안 가열하여 열수 추출한 추출액을 마련한 다음, 추출액이 상온이 될 때까지 서냉시킨다. 그리고 추출액에 락토바실러스(Lactobacillus) 액상 종균을 접종한 다음 2일 동안 산소가 공급되는 발효장치에서 발효한다.And 500 g of water, 10 g of water, and 10 liters of water are placed in a pan and heated for 4 hours to obtain an extract. The extract is slowly cooled to room temperature. Then, the extract is inoculated with Lactobacillus liquid phase and fermented in an oxygenated fermenter for 2 days.
불린 대두를 마쇄하고 가열 후 여과하여 두유를 얻고, 두유 100kg에 오미자 즙과 강황 분말을 포함하는 혼합물 500g, 초석잠 추출액 1kg, 천패모, 괴화 열수추출 발효액 500g을 혼합하고 가열한 다음 응고제를 넣고 성형하여 두부 제조를 완료한다.The thus-obtained soybean milk was filtered and heated to obtain soybean milk. To 100 kg of soybean milk, 500 g of a mixture containing omiza juice and turmeric powder, 1 kg of cornstarch sleep extract, 500 g of chrysanthemum morifolium and 500 g of fermented broth of hot water extract, To complete the manufacture of the tofu.
[비교예 1][Comparative Example 1]
상기 실시예 1에서 오미자 즙을 생략하는 대신 증숙하지 않은 강황 분말 100g을 두유에 혼합한 것을 제외하고 동일한 방법으로 두부를 제조하였다.Tofu was prepared in the same manner as in Example 1, except that 100 g of unripe steamed grain powder was mixed with soy milk instead of omija juice.
[비교예 2][Comparative Example 2]
상기 실시예 1에서 천패모와 괴화를 열수 추출만 하고, 발효하지 않은 것을 제외하고 동일한 방법으로 두부를 제조하였다.Tofu was prepared in the same manner as in Example 1, except that the mixture was subjected to hot water extraction and fermentation was not performed.
이하에서는 실시예 1 및 비교예 1, 2에서 제조된 두부의 맛과 전체적인 기호도를 알아보기 위하여 35명의 패널을 선정하여 5점 평점법 (5: 아주 좋다, 4 : 좋다, 3 : 보통이다, 2 : 나쁘다, 1 : 아주 나쁘다)으로 분석하였으며, 결과 값을 평균 값으로 하여 아래 표 1에 정리하였다.In order to examine the taste and overall taste of the tofu prepared in Example 1 and Comparative Examples 1 and 2, 35 panelists were selected and evaluated according to the 5-point scale method (5: very good, 4: good, 3: : Bad, 1: very bad). The results are summarized in Table 1 below.
위 표 1을 통해 확인할 수 있듯이 실시예 1의 방법으로 제조된 기능성 물질이 함유된 두부는 맛과, 전체적인 기호도에서 좋다는 평가를 받았다.As can be seen from the above Table 1, the tofu containing the functional material prepared by the method of Example 1 was evaluated as good in taste and overall taste.
또한, 본 발명에 따른 두부에는 평소 음식을 통해 섭취하기 어려운 강황, 오미자, 초석잠, 천패모, 괴화 등에 함유된 유효성분을 손쉽게 섭취할 수 있는 장점이 있다.In addition, the tofu according to the present invention has an advantage of being able to easily ingest an active ingredient contained in turmeric, omija, cornerstone sleep, gingiva, calf, etc. which is difficult to be ingested through usual food.
한편, 본 발명의 상세한 설명 및 첨부도면에서는 구체적인 실시예에 관해 설명하였으나, 본 발명은 개시된 실시예에 한정되지 않고 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 여러 가지 치환, 변형 및 변경이 가능하다. 따라서, 본 발명의 범위는 설명된 실시예에 국한되어 정해져서는 안되며 후술하는 특허청구범위뿐만 아니라 이 특허청구범위와 균등한 것들을 포함하는 것으로 해석되어야 할 것이다.While the present invention has been described in connection with what is presently considered to be practical exemplary embodiments, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, It is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, is intended to cover various modifications and similarities. Accordingly, the scope of the present invention should be construed as being limited to the embodiments described, and it is intended that the scope of the present invention encompasses not only the following claims, but also equivalents thereto.
Claims (5)
오미자 즙을 마련하는 S2단계와;
상기 오미자 즙 100중량부를 기준으로 증류수 50~150중량부와, 상기 강황 분말 10~30중량부와, 잔탄검 또는 구아검 1~5중량부를 혼합한 다음, 70~90℃에서 30~50분 동안 가열한 혼합물을 제조하는 S3단계와;
초석잠을 열수추출한 추출액을 마련하는 S4단계와;
천패모와, 괴화를 열수추출한 다음, 발효, 숙성시키는 S5단계와;
불린 대두를 마쇄하고 가열 후 여과하여 두유를 얻는 S6단계와;
상기 두유 100중량부에 상기 S3단계에서 제조된 혼합물 0.1~1중량부와, 상기 S4단계 초석잠 추출액 1~3중량부와, 상기 S5단계의 발효액 0.1~1중량부를 혼합하고 가열하는 S7단계와;
상기 S7단계에서 가열한 혼합물에 응고제를 넣고 성형하는 S8단계;
를 포함하는 것을 특징으로 하는 기능성 물질이 함유된 두부 제조방법.
A step S1 of smoothing the sulfuric acid, drying it, and pulverizing the dried sulfuric acid to prepare a sulfur powder;
Step S2 of preparing omija juice;
50 to 150 parts by weight of distilled water, 10 to 30 parts by weight of the sulfurized powder, and 1 to 5 parts by weight of xanthan gum or guar gum are mixed with 100 parts by weight of the above omija juice, and the mixture is stirred at 70 to 90 ° C for 30 to 50 minutes Preparing a heated mixture;
(S4) of preparing an extract to be extracted as hot stone water;
(S5) of fermenting and aging the raw bean, followed by hydrothermal extraction;
S6 step of grinding the so-called soybeans, heating and filtering to obtain soybean milk;
Step S7 is a step of mixing and heating 0.1 to 1 part by weight of the mixture prepared in the step S3, 1 to 3 parts by weight of the sleeping extract of the step S4 and 0.1 to 1 part by weight of the fermentation solution of the step S5 in 100 parts by weight of the soybean milk ;
Step S8 of injecting a coagulant into the mixture heated in step S7 and molding the mixture;
The method of manufacturing a tofu containing a functional material according to claim 1,
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160109112A KR101706019B1 (en) | 2016-08-26 | 2016-08-26 | The tofu manufacturing method of containing the functional active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160109112A KR101706019B1 (en) | 2016-08-26 | 2016-08-26 | The tofu manufacturing method of containing the functional active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101706019B1 true KR101706019B1 (en) | 2017-02-10 |
Family
ID=58121421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160109112A KR101706019B1 (en) | 2016-08-26 | 2016-08-26 | The tofu manufacturing method of containing the functional active ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101706019B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102061048B1 (en) * | 2018-09-03 | 2019-12-31 | 한국식품연구원 | A composition for the improving of diabetes comprising Schisandra chinensis and soymilk, and method for preparing the same |
KR20230083432A (en) * | 2021-12-03 | 2023-06-12 | 백봉현 | Manufacturing method of tofu using omija and tofu unsing omija |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120088061A (en) * | 2010-11-19 | 2012-08-08 | 공주대학교 산학협력단 | Soybean Curd and Method of Manufacturing the Same |
KR101209366B1 (en) * | 2012-03-29 | 2012-12-06 | 김상권 | The manufacturing method of whole soybean curd with rice |
KR101323968B1 (en) * | 2011-09-07 | 2013-11-08 | 어진영농조합법인 | Method for manufacturing powder bean curd having turmeric and the Powder Bean Curd thereby |
KR20140080906A (en) | 2012-12-20 | 2014-07-01 | 대한민국(농촌진흥청장) | Manufacturing method of colored bean-curd containing natural pigments and thereby made colored bean-curd |
KR101581647B1 (en) | 2015-09-24 | 2015-12-30 | 김석원 | Process for preparing bean-curd |
KR101613045B1 (en) | 2015-11-11 | 2016-04-15 | 김석원 | Process for preparing bean-curd using various fruits |
KR101628995B1 (en) * | 2015-10-23 | 2016-06-09 | 이종두 | Natural extracts, and natural somatid gel method and a multi-functional material powder prepared using the same composition |
-
2016
- 2016-08-26 KR KR1020160109112A patent/KR101706019B1/en active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120088061A (en) * | 2010-11-19 | 2012-08-08 | 공주대학교 산학협력단 | Soybean Curd and Method of Manufacturing the Same |
KR101323968B1 (en) * | 2011-09-07 | 2013-11-08 | 어진영농조합법인 | Method for manufacturing powder bean curd having turmeric and the Powder Bean Curd thereby |
KR101209366B1 (en) * | 2012-03-29 | 2012-12-06 | 김상권 | The manufacturing method of whole soybean curd with rice |
KR20140080906A (en) | 2012-12-20 | 2014-07-01 | 대한민국(농촌진흥청장) | Manufacturing method of colored bean-curd containing natural pigments and thereby made colored bean-curd |
KR101581647B1 (en) | 2015-09-24 | 2015-12-30 | 김석원 | Process for preparing bean-curd |
KR101628995B1 (en) * | 2015-10-23 | 2016-06-09 | 이종두 | Natural extracts, and natural somatid gel method and a multi-functional material powder prepared using the same composition |
KR101613045B1 (en) | 2015-11-11 | 2016-04-15 | 김석원 | Process for preparing bean-curd using various fruits |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102061048B1 (en) * | 2018-09-03 | 2019-12-31 | 한국식품연구원 | A composition for the improving of diabetes comprising Schisandra chinensis and soymilk, and method for preparing the same |
KR20200026767A (en) * | 2018-09-03 | 2020-03-11 | 한국식품연구원 | A composition for the improving of diabetes comprising Schisandra chinensis and soymilk, and method for preparing the same |
KR102304942B1 (en) * | 2018-09-03 | 2021-09-27 | 한국식품연구원 | A composition for the improving of diabetes comprising Schisandra chinensis and soymilk, and method for preparing the same |
US20220117275A1 (en) * | 2018-09-03 | 2022-04-21 | Korea Food Research Institute | Food composition, for alleviating diabetes, comprising schisandra chinensis fruit juice and bean juice and preparation method thereof |
EP3912482A4 (en) * | 2018-09-03 | 2022-11-23 | Korea Food Research Institute | Food composition, for alleviating diabetes, comprising omija and bean juice, and preparation method thereof |
KR20230083432A (en) * | 2021-12-03 | 2023-06-12 | 백봉현 | Manufacturing method of tofu using omija and tofu unsing omija |
KR102639938B1 (en) | 2021-12-03 | 2024-02-23 | 백봉현 | Manufacturing method of tofu using omija and tofu unsing omija |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101723206B1 (en) | Pills for health supplement food comprising extracts of protaetia brebitarsis larba and manufacturing method for the same | |
JP4616413B1 (en) | Fermented food manufacturing method and fermented food | |
CN102742911A (en) | Enzyme herbal tea and preparation method thereof | |
KR101386879B1 (en) | Method for producing a fermentation food using mixed lactic acid bacteria and a fermentation food | |
KR101748948B1 (en) | Fermented Moringa beverage and method thereof | |
CN103960358A (en) | Peony yogurt and preparation method thereof | |
KR101706019B1 (en) | The tofu manufacturing method of containing the functional active ingredient | |
CN102578528B (en) | Health care fermented black beans containing Chinese herbal medicine and production process thereof | |
KR101681421B1 (en) | A method for producing vinegar of Moringa oleifera | |
KR102002337B1 (en) | A manufacturing method of Cheong Kuk Jang having red ginseng paste | |
KR101753966B1 (en) | Moringa pepper paste and preparation method thereof | |
KR102017341B1 (en) | Feed composition for pork pig | |
KR101793230B1 (en) | Manufacturing method of Beverage using Rice Bran | |
KR20110109105A (en) | Manufocturing method of malt to eat by rice and manufacturcd malt by the method | |
KR101864658B1 (en) | The method of manufacturing a scorched-containing Wild grape juice and Gastrodia elata Blume | |
CN104543358A (en) | Feed for Lingkun chicken raised in bamboo groves and preparation method thereof | |
CN104543470A (en) | Feed for Hongshan chicken raised in bamboo groves and preparation method thereof | |
KR101203790B1 (en) | Method for manufacturing soybean paste including butterbur and soybean paste thereof | |
KR101918440B1 (en) | Method for manufacturing an oil-and-honey pastry | |
KR20220027657A (en) | Tofu manufacturing method with functional active ingredients | |
KR20060107217A (en) | Bread and rice cake containing monascus extracts | |
KR101690415B1 (en) | Health food using chlorophyll, embryo bud of rice, gastrodia elata, chia seed | |
KR101941600B1 (en) | Functional Fermented Soybean Lump using Enzymes and Manufacturing method thereof | |
KR102527825B1 (en) | Manufacturing method of condensed milk cream for baguette and condensed milk cream manufactured by the same | |
KR102648858B1 (en) | Method for manufacturing pine-nut cream and pine-nut cream manufactured by the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20200206 Year of fee payment: 4 |